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The expressed primary B cell repertoire is extremely diverse (1-3); however, 
certain clonotypes or clonotype families are disproportionately represented in 
mature B cell pools of various inbred murine strains (4-13).  Numerous studies 
have indicated a determinative role for variable (V) t region gene expression in 
the  establishment  of the  primary  B  cell  repertoire.  Molecular analyses  have 
demonstrated  a  very  large  genetically  encoded  repertoire  arising  from  the 
arrangement of the V region genes into multiple V, D (diversity), and J (joining) 
segments,  the  combinatorial  rearrangements of these  segments (14-17),  and 
diversity  at  the junctions  of rearranged  segments  (18,  19).  Studies  of bone 
marrow  B  cell  precursors  have  demonstrated  that  both  the  diversity  of the 
primary  B  cell  repertoire  and  the  unusually  high  representation  of certain 
clonotypes are  characteristics of the  newly generated  B  cell  population  even 
before surface immunoglobulin (sIg) expression (20-27). 
Environmental modulation of the genetically encoded repertoire in the form 
of tolerance (21,  28-31)  and  T  cell  or  antibody-mediated idiotypic  network 
effects (6, 10, 32-41) may significantly alter the expression of certain specificities, 
and thereby participate  in  the establishment of the primary B cell repertoire. 
Thus, assessing the relative contribution of genetically encoded vs. environmental 
influences  on  the  differential  expression  of predominant  clonotype  families 
among various murine strains is essential for an understanding of the establish- 
ment of the functional mature B cell repertoire. 
To further evaluate the mechanisms responsible for strain-specific differences 
in the expression of predominant clonotypes, we have studied T  cell-dependent 
responses to Dextran B1355 fraction S (DEX). Antibodies specific for DEX can 
be divided into two broad categories based on the recognized glucose linkage 
conformation: antibodies specific for 0~(1 --~ 3) glucose linkages, and those specific 
for a(1  ~  6) linkages (7-9).  Mice of the Igh" heavy chain haplotype are high 
responders to a(1  --~ 3) linkages, with a  marked dominance (80-95%)  of anti- 
bodies bearing both the ), light chain and crossreactive idiotypes (IdX) (7-9, 35, 
38-40,  42-44).  In contrast, mice of the Igh  b hapiotype express little ),-bearing 
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a(1  --~ 3) linkage-specific antibodies (7-9,  35,  38-40).  Historically, this pheno- 
typic difference has  been  considered to  represent a  polymorphism in  the  VH 
(variable heavy chain) genes encoding antibody of this specificity between these 
strains, and as such, has been the prototype antigen used to map recombinants 
within Igh between strains (7-9). 
Using the splenic fragment culture system, we have examined the ~-bearing 
oL(1 --~  3)  DEX-specific  B  cell  repertoire  in  BALB/c (Igh") and  C.B20  (Igh  b) 
mice, in order to probe the mechanisms underlying the phenotypic difference in 
these two strains. Our studies have shown that DEX-responsive precursor cells 
in both splenic and environmentally naive surface slg- bone marrow cell popu- 
lations (prereceptor B cells) obtained from BALB/c mice consist predominantly 
of cells  that  give  rise  to  clones  secreting  ~-bearing  a(1  ---* 3)  DEX-specific 
antibodies. Surprisingly, the sIg- bone marrow cell population, in contrast to the 
spleen cell population of C.B20 mice also contains a predominant population of 
DEX-responsive  cells  whose  antibody-forming cell  clonal  progeny secrete  ~,- 
bearing o~(1 --~  3)  DEX-specific antibodies.  The absolute  frequency of these 
C.B20 ~,-bearing  a(1  --> 3) DEX-specific prereceptor B cells is equivalent to the 
frequency in sIg- BALB/c bone marrow cell populations. The C.B20 )~-bearing 
~(1  --o 3) DEX-specific pre-receptor B cells can be effectively stimulated in the 
allogeneic Igh  ~ (BALB/c) splenic  fragment environment, but  not  in  the  Igh  b 
syngeneic (C.B20) environment. Since ~,-bearing  or(1 --* 3) DEX-specific splenic 
B cells are extremely rare in C.B20 mice, it appears that, if allowed to mature 
through sIg acquisition within their natural C.B20 environment, these cells are 
inactivated, and cannot respond in either the Igh  a or Igh  b environment. There- 
fore,  the  C.B20  ~-bearing  a(1  -->  3)  DEX-specific  B  cell  population  can  be 
characterized as a  silenced clonotype family. Thus,  the phenotypic difference 
between BALB/c and C.B20 mice, as regards to this clonotype family, appears 
to be the result of C.B20 environmental clonotype-specific downregulation, and 
not a polymorphism in the V, genes coding for these specificities. 
Materials and Methods 
Mice.  BALB/c and C.B20 mice were obtained from the breeding colony at Scripps 
Clinic and Research  Foundation. Mice of either sex, 6-12 wk of age, were used in the 
splenic fragment culture experiments. 
Antigens and Immunizations.  Limulus polyphemus hemocyanin (Hy) and bovine serum 
albumin (BSA) were coupled to Dextran B1355 fraction S, as previously described (35). 
Dextran B1355  fraction  S (DEX) [35% a(1  ~  3) linkages] was a  gift from Dr.  M.  E. 
Slodki, Northern Regional Research Laboratory, U.S. Department of  Agriculture, Peoria, 
IL. Dextran  B512 [96% a(1  ~  6)] was obtained from Sigma Chemical Co., St.  Louis, 
MO. 
6-10-wk-old  BALB/c and C.B20 mice were immunized intraperitoneally  with 100 #g 
Hy in complete  Freund's adjuvant (CFA), and boosted with  I00 #g Hy in saline 4 wk 
later. Mice were used 4-8 wk after boosting as recipients for cell transfers. 
Splenic Fragment Cultures.  Monoc|onal anti-DEX antibodies were produced in splenic 
fragment cultures as previously described (11, 25, 35, 43, 45). Briefly, 2.5 X 10 7 donor 
spleen cells or 5.0 x  10 ? unfractionated bone marrow cells or bone marrow cells depleted 
of sIg  + B cells (see below) were transferred intravenously into Hy-primed recipient mice 
that had received  1,300 rad  whole body irradiation  from a  Cs source  1-4  h  earlier. 
Fragment cultures were prepared from recipient spleens 16-20 h after cell transfer, and 
were stimulated for 3 d with DEX-Hy. Cultures were incubated at 37 °C in an atmosphere 1622  SILENCING OF  A  PREDOMINANT  CLONOTYPE  FAMILY 
of 93%  02  and  7%  COz.  Medium  was changed  every 2-4  d,  and  culture  fluids  were 
individually collected from days 9-24 and assayed for antibody activity. 
Radioimmunoassay  (RIA) and Competitive Inhibition  Studies.  Culture  supernatants col- 
lected between day 9 and 24 of culture were assayed for DEX-specific antibodies by solid- 
phase RIA, by a method previously described (3,  11, 25, 35, 45, 46). Murine DEX-specific 
antibodies  bound  to  DEX-BSA-coated polyvinyl microtiter  plates  were  detected  after 
reaction with polyspecific rabbit anti-mouse Ig antisera followed by affinity-purified 125I- 
goat anti-rabbit Ig. For Ig light chain analyses, rabbit affinity-purified anti-~,- or anti-K- 
specific  reagents  (Litton  Bionetics,  Inc.,  Kensington,  MD)  were  used  instead  of  the 
polyspecific rabbit serum. 
The linkage conformation specificity was determined by inhibition of antibody binding 
to DEX-BSA plates by Dextran B 1355 fraction S and Dextran B512 (35).  Equal volumes 
of Dextran B1355 fraction S or Dextran B512 and fragment culture supernatants were 
added to DEX-BSA-coated microtiter plates, and the inhibition of binding was assessed. 
Final concentrations of inhibitors were 500 #g/ml. Antibodies inhibited by only Dextran 
B1355  fraction  S were defined as being specific for a(1  ~  3)  linkages, whereas those 
inhibited by both Dextran  B1355  fraction S and Dextran  B512  were defined as being 
specific for a(1 ~  6) linkages. No antibodies were inhibited by only Dextran B512. 
Competitive  inhibition  solid  phase  RIA  for  IdX  determinants  were  performed  as 
previously described (11, 25, 44). Briefly, 96-well microtiter plates were coated with CD3, 
a  monoclonal anti-ldX  originally produced by J.  Kearney (University of Alabama, Bir- 
mingham), and  generously supplied  by  Dr.  B.  Clevenger (Washington  University,  St. 
Louis, MO). Test antibodies were identified as IdX  + if their inhibition of the binding of 
v"~I-labeled M 104E (Litton Bionetics, Inc.) was greater than or equal to an equal concen- 
tration of M 104E. 
Depletion of slg + B Cells from Bone Marrow Cell Populations.  slg- cells from adult bone 
marrow were prepared by a modification of rosetting techniques already described (20- 
25,  47,  48).  In  brief,  107-109  washed  bone marrow cells,  obtained as pools from the 
femurs and tibias of BALB/c or C.B20 mice, were incubated with a 5-10-fold excess of 
tanned, glutaraldehyde-fixed sheep red blood cells coated with goat anti-mouse IgM and 
IgG heavy- and light chain-specific antibody (Kirkegaard and Perry Laboratories, Inc., 
Gaithersburg, MD). Rosetted bone marrow cells (sIg  ÷) were removed by centrifugation at 
4°C through Ficoll-Hypaque density gradients. 30-50% of the input bone marrow cells 
were generally recovered in the interface band.  At least 90% of sIg  + lymphocytes were 
depleted by this method, and the sIg- cell preparations possessed <2% slg  ÷ lymphocytes, 
as  assessed  by  direct  fluorescence  analysis  employing  fluorescein-labeled  rabbit  anti- 
mouse (IgM, IgG, and IgA) F(ab')2 fragments (Zymed Laboratories, Burlingame, CA) on 
a Becton-Dickenson FACS IV. 
Transfer  Fusion.  Hybridoma lines were established using the SP2/0 cell line originally 
described by Shuhnan et al. (49), in a transfer fusion procedure similar to that previously 
described (50, 51). Normal B cell fusion partners were obtained by the following protocol: 
Recipient BALB/c mice were immunized with Hy in CFA, boosted 4 wk later with Hy in 
saline, and used as recipients 4-8 wk thereafter.  5 d before fusion, recipient mice were 
irradiated at 800 tad, and 2-4 h later given 108 donor C.B20 unfractionated bone marrow 
cells intravenously. 2 h after the transfer of donor cells,  recipient mice received 100 #g 
DEX-Hy intravenously. Recipient mice were fed water treated with puromycin. 
5 d after cell transfers, the recipient mice were killed, their spleens were removed, and 
a  cell suspension  was prepared.  The number of nucleated  cells recovered per  spleen 
ranged between 8 ×  106 and 4 ×  107, and at least two spleens were pooled per fusion. 
The spleen cells were mixed with SP2/0 cells at a ratio of 30:1 spleen cells to SP2/0 cells, 
and fusions were carried out at room temperature using 50% wt/vol polyethylene glycol 
(3,500 mol wt) in Dulbecco's Modified Eagle's medium containing 15% dimethylsulfoxide 
(52).  Ceils  were  washed  after  fusion,  and  plated  out  in  96-well  microtiter  plates  in 
hypoxanthine, aminopterin, thymidine (HAT) selective medium. Hybrids were fed twice 
weekly in HAT media for 10 d, then maintained in hypoxanthine and thymidine  10  d 
further.  Usually,  10-14  d  after fusion, wells  containing hybrid cells required  splitting, FROSCHER  AND  KLINMAN  1623 
and at  this stage the supernatants  were collected and assayed  for the presence  of DEX- 
specific antibody.  Positive hybrids  were cloned twice at  limiting dilution,  and  subclones 
were grown  in  large quantities.  Culture  fluids were saved and  cells were transferred  to 
pristane-primed  BALB/c mice for the production  of ascites fluid. 
Results 
X-bearing o~(1 ---* 3) Linkage-specific DEX-responsive  Cells in BALB/c Splenic and 
slg- Bone Marrow Cell Populations.  Results of an analysis of DEX-Hy-responsive 
cells  in  BALB/c  spleen  and  sIg-  bone  marrow  cells  in  the  splenic  fragment 
culture system are  summarized in Table  I.  The frequency (18.4  cells per  l0 s 
injected cells) of X-bearing a(1  ~  3) DEX-responsive cells, and the percentage 
(87%)  of  the  total  DEX  response  this  clonotype  family  represents  in  the 
BALB/c spleen cell population were consistent with previous reports (35,  42, 
43).  We  calculate  that  1/87,000  injected B  cells expressed  this phenotype by 
assuming, as has been previously determined, that 50%  of the injected spleen 
cells  are  B  cells,  and  that  the  efficiency  of both  homing and  stimulation  in 
fragment cultures is 4% (1, 3, 53). The frequency of X-bearing a(1 ~  3) DEX- 
specific cells of BALB/c spleen cell populations transferred into the Igh  b alloge- 
neic  C.B20  recipients  was  quite  similar  (1/92,000  injected  B  cells),  and  also 
represented  87%  of the total  DEX-specific responses obtained.  Therefore,  re- 
sponsiveness to DEX  and the expression of the predominant clonotype family 
was equivalent when BALB/c spleen cells were stimulated in either Igh  ~ syngeneic 
or Igh  b allogeneic environments. 
When  sIg-  bone marrow cells were stimulated with  DEX-Hy  in either Igh- 
syngeneic or -allogeneic, carrier-primed, irradiated recipients, the frequencies of 
X-bearing a(1  ~  3) DEX-responsive  B cells were  1.3 and  1.8 per  l0 s injected 
cells, respectively. The ratio of the frequencies of responsive cells of this clono- 
TABLE  I 
X-bearing c~(1 --* 3) Linkage-specific DEX-responsive Cells in 
BALB/c Splenic and slg- Bone Marrow Cells 
Source of BALB/c cells* 
Total cells 
Hy-primed  injected 
recipient*  (X 10S)  ~ 
Percent of total 
),-bearing  anti-DEX 
a(l --* 3) DEX-  responses 
specific  producing 
monoclonal  X-bearing 
responses  a(1 ~  3) 
per 10 a  linkage-specific 
injected cells  ~  antibodies 
Spleen cells  BALB/c  500  18.4  87 
C.B20  950  17.7  87 
slg- bone marrow cells  BALB/c  1,800  1.3  81 
C,B20  600  1.8  72 
* BALB/c donor mice were 2-4 mo old. 
* Recipient mice were primed with Hy in CFA, boosted with Hy in saline 4 wk later. 4-6 wk after 
boosting, they received 1,300 rad followed in 1-4 h by cell transfer. 
0 Each recipient mouse received 2.5 ×  107 pooled spleen cells or 5.0 x  107 slg- bone marrow cells 
intravenously. 
I Antibody-producing clones were detected by RIA of culture fluids collected from days 9-24  of 
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TABLE  II 
X-bearing a(1 ~  3) Linkage-specific DEX-responsive Cells in 
C.B20 Splenic and Bone Marrow Cell Populations 
Total 
Source of C.B20 ceils  Hy-primed  cells 
recipient  injected 
(x 106) 
Percent of total 
h-bearing  anti-DEX 
a(1 ---) 3) DEX-  responses 
specific  producing 
monoclonal  h-bearing  responses  a(1 ~  3) 
per 108 
injected  linkage- 
specific 
ceils  antibodies 
Spleen cells  C.B20  1,300  1.5  12 
BALB/c  2,600  1.0  8 
slg- bone marrow cells  C.B20  1,225  0.2  6 
BALB/c  1,700  1.8  53 
Unfractionated bone marrow cells  C.B20  835  0.5  15 
BALB/c  1,100  1.4  47 
Procedures and cell treatments as in Table I. 
type, on a  per-injected-cell basis in  BALB/c Ig- bone marrow vs.  spleen cells, 
was 0.07 in the Igh  a recipients, and 0.1 in Igh  b recipients. These ratios are within 
the range of frequency ratios of responses of sIg- vs. spleen cell populations for 
numerous antigens studied to date, including 2,4-dinitrophenyl (DNP), phospho- 
rylcholine (PC),  and the hemagglutinin of the PR8  influenza virus (PR8-HA) 
(20-25).  Thus,  neither  the  Igh  a nor  Igh  b environment appears  to  alter  the 
number of responsive BALB/c X-bearing a(1 --) 3) DEX-specific B cells or sIg- 
B cell precursors. 
X-bearing o~(1 ----) 3) Linkage-specific  DEX-responsive  Cells in  C.B20 Splenic  and 
Bone Marrow Cell Populations.  Previous studies have shown that, in contrast to 
the response of BALB/c mice, the DEX-specific response of Igh  b mice is relatively 
low overall, and that none, or only a  very small proportion of this response is 
characterized by antibodies bearing the X light chain (7-9,  40).  In agreement 
with these reports, the observed frequency of DEX-Hy-responsive C.B20 spleen 
cells (12.9  per  108  injected cells) was lower than that for BALB/c spleen cells 
(21.2 per 108 injected cells). The frequency was the same whether C.B20 spleen 
cells were  stimulated  in  either  the  Igh  b syngeneic C.B20  or  Igh  ~ atlogeneic 
BALB/c Hy-primed, irradiated recipients. Of these responding cells, only a small 
percentage (8-12%), representing fewer than 1/106 C.B20 splenic B cells, yielded 
clones secreting X-bearing monoclonal antibodies specific for the a(1 --) 3) linkage 
group (see Table II). 
As  anticipated  from  the  low  number of X-bearing  a(1  ~  3)  DEX-specific 
C.B20  spleen cells, sIg-  C.B20  bone marrow cells stimulated in  the syngeneic 
C.B20 environment yielded only 0.2 X-bearing a(1 --~ 3) DEX-specific responses 
per 108 injected cells.  In marked contrast, however, when this same cell popula- 
tion was stimulated in the Igh" allogeneic BALB/c environment, the frequency 
of X-bearing a(1 ---) 3) DEX-specific responses was ninefold higher (1.8 per 108 
injected sIg- bone marrow cells), and represented 53% of all DEX-Hy-responsive 
cells in  this population.  Thus, there was an equivalent number of potential  X- FROSCHER  AND  KLINMAN  1625 
bearing ol(1 ~  3)  DEX-responsive cells in  both  the C.B20  and BALB/c sIg- 
bone marrow cell populations. However, this population of C.B20 sIg- precursor 
cells  could only be  stimulated  to  respond  to  DEX-Hy in  the  Igh  a allogeneic 
carrier-primed BALB/c environment. 
These findings indicate that, although equivalent numbers of X-bearing a(1 
3) DEX-specific precursor cells emerge from C.B20 and BALB/c bone marrow 
stem cells, C.B20 cells of this phenotype can neither be stimulated by DEX-Hy 
in their syngeneic environment, nor can they mature into splenic B cells in situ. 
To determine the developmental stage at which X-bearing a(1 --~ 3) DEX-specific 
C.B20 B cells are inactivated, we assessed the frequency of DEX-Hy-responsive 
cells in unfractionated C.B20 bone marrow cells (Table II). Again, the number 
of X-bearing a(1 ~  3) DEX-specific cells responsive in syngeneic Igh  b recipients 
was substantially less than in the Igh  a environment. However, the number of X- 
bearing ~(1  --* 3) DEX-responsive cells, even in BALB/c recipients, was lower 
on a per-injected-cell basis (1.4 per 10 a injected cells) than was the frequency for 
sIg- cells (1.8 per 108 injected cells).  Thus, it appears that there are few, if any, 
X-bearing a(1 ~  3) DEX-specific sIg  ÷ bone marrow B cells in C.B20 mice. This 
implies that potentially responsive C.B20  precursor cells of this clonotype are 
apparently rendered nonresponsive to DEX-Hy (silenced) by an environmental 
regulatory mechanism functioning in temporal association with the acquisition, 
in the bone marrow, of their sIg receptors. 
X-bearing  ct(l  --* 3) Linkage-specific  Hybridoma  Monoclonal  Antibodies  Derived 
from  C.B20 Bone Marrow  Cells  by  Transfer  Fusion.  To  qualitatively study the 
DEX-specific antibodies derived from C.B20  bone marrow cells, we have ob- 
tained hybridomas by the transfer of C.B20 bone marrow cells to permissive Hy- 
primed, irradiated BALB/c recipients for stimulation and subsequent transfer 
fusion (50, 51). From two separate fusions, a total of 15 DEX-specific hybridomas 
were obtained.  Of these,  nine  (60%)  were r-bearing and  a(1  --~ 6)  linkage- 
specific,  and  six  (40%)  were  X-bearing  and  ~(1  --~  3)  linkage-specific.  This 
represents a distribution of specificities similar to that found using C.B20 bone 
marrow cells in the splenic fragment culture system. All six X-bearing a(1 ~  3) 
DEX-specific  hybridoma antibodies  of C.B20  origin  bore  the  IdX  idiotypic 
determinant, as defined by their inhibition of binding of M 104E to the mono- 
clonal anti-IdX antibody, CD3. 
Discussion 
The composition of the expressed primary B cell repertoire is the product of 
both  the utilization of V  region gene elements in  cells emerging in  the adult 
bone marrow, and receptor-specific environmental influences acting on maturing 
cells of each  unique  clonotype.  Previous  studies  in  this  laboratory  (23)  have 
shown that, at least for the immune response to one antigen (PR8-HA), there is 
substantial repertoire diversity before V  region-specific environmental regula- 
tory  effects are  encountered.  However,  the  extent  to  which  environmental 
influences, in the form of tolerance induction and/or idiotypic network interac- 
tions,  may influence the expression of the mature B cell repertoire is still  not 
known. As clone-specific environmental influences on the B cell repertoire are 
presumably mediated by the clonally distributed V regions of the sIg receptors, 
bone marrow cells depleted of sIg  + cells should contain only sIg- pre-B cells that 
have not been subjected to environmental regulatory mechanisms. In previous 1626  SILENCING  OF  A  PREDOMINANT  CLONOTYPE  FAMILY 
studies (20-25) we have shown that cells within this sIg- pool apparently acquire 
sIg receptors and respond to antigenic stimulation in fragment cultures. Addi- 
tionally, these cells are relatively immature by the criteria of tolerance suscepti- 
bility and potential for isotype expression (20-25). Thus, by analyzing responses 
of these prereceptor B cells, stimulated in different environments, the selective 
effects of genetic and of postgenetic environmental influences on the repertoire 
can be evaluated. 
Antigens that induce immune responses unique to various murine strains have 
been useful tools for examining mechanisms affecting B cell repertoire expression 
(4-13).  In these systems, the phenotypic differences of the antibody responses 
may be the result of either polymorphism in the relevant V region gene pools of 
various strains, or differences in the postgenetic environmental molding of the 
B cell repertoire in each strain. For several responses, including murine responses 
to  azophenylarsonate  (ARS),  PC,  and  DEX,  strain-specific  differences  have 
already been attributable to polymorphisms in inherited heavy or light chain V 
region genes (54-56).  Polymorphism in genes other than those encoding Ig V 
regions may also affect repertoire expression. The control of the frequency of 
mature  PC  responsive  B  cells in  various  murine strains  appears  to  be  under 
multigenic control (57),  and in  mice with the CBA/N  sex-linked immunologic 
defect, PC-responsive cells are generated normally, but are eliminated by envi- 
ronmental mechanisms once they express their sIg receptors (25). 
The studies in  this report have used the splenic fragment culture system to 
evaluate the origin of the well-established phenotypic difference in the h-bearing 
ol(1 ~  3) DEX-specific response in BALB/c (Igh  a) (high responder) and C.B20 
(Igb  b) (low responder) mouse strains, by evaluating the response to DEX-Hy of 
spleen cells and sIg-  bone  marrow cells from these two strains  in  Hy-primed 
BALB/c and  C.B20  recipients.  The  frequency of h-bearing c~(1 --~  3)  DEX- 
responsive BALB/c splenic B cells was N ! :5 X 106 injected cells, and represented 
87%  of the total  response to  Dextran  B1355S  in  either Igh  a or Igh  b carrier- 
primed irradiated recipients. This frequency is consistent with that reported by 
other laboratories (35, 40, 42, 43) using the splenic fragment culture technique 
to assess precursor cell populations responsive to DEX in BALB/c mice, and tbus 
confirms the conclusion of these laboratories that  the  h-bearing DEX-specific 
antibody clonotype family dominates the DEX-responsive splenic B cell popula- 
tion even before overt immunization. The frequency of sIg- bone marrow cells 
of this clonotype that are responsive in Igh  a and Igh  b recipients was 1.3 and 1.8 
per 10 ~ injected cells, respectively. Again, this represented the vast majority of 
cells responsive to DEX.  The ratio of splenic B cells vs. sIg- precursor cells of 
this clonotype in  BALB/c mice was consistent with the ratio of splenic to sIg- 
responsive cells observed  for several antigens,  including influenza virus  PR8 
antigens,  PC,  and  DNP  (20-25).  Thus,  as was the case for PC  (25),  the high 
frequency of precursor cells of the predominant clonotype family appears  to 
reflect a similarly high rate of expression of the relevant V regions in the bone 
marrow stem cell pool, rather than environmental up-regulation. These findings 
are consistent with the interpretation of findings of other investigators concern- 
ing the generation of Igh  b cells bearing the NP  b idiotype (26) and BALB/c cells 
bearing the MOPC 460 idiotype (27). Thus, in all instances reported to date, the 
expression of a  high frequency of a given clonotype or clonotype family in the FROSCHER AND  KLINMAN  1627 
mature primary B cell pool can be attributed to a high level of expression of the 
V regions necessary for that clonotype in B cell precursors in the bone marrow 
generative cell pool. 
Recently, Near et al. (54), have reported that the expression of the V region 
genetic elements responsible for the p-azophenylarsonate (ARS) IdX in A/J mice 
is consistent with the extent of use of each of these elements per se within the 
entire preimmune B cell population. These investigators concluded that the level 
of expression of a given clonotype is the product of the stochastic probability of 
rearrangements of the appropriate gene elements from within the V region gene 
pool.  This  occurrence would  be  relatively rare  for  the  ARS  IdX,  which  is 
dependent on  the use of the single appropriate  V.,  VL (variable region light 
chain), and JL, with little leeway with respect to permisable D, JH, and junctional 
diversity (58).  Thus,  it  is  not surprising that Sigal (59) demonstrated that  the 
representation of B cells expressing ARS IdX in A/J primary splenic B cells is at 
most only 1 in 2.8 x  10 6 B cells. In this context, the much higher expression of 
the ~,-bearing a(1 ~  3) DEX-specific clonotype family in both splenic and sIg- 
BALB/c precursor cells would require a higher probability of the expression of 
involved  V  region  genetic  elements  for  it  to  be  the  product  of  stochastic 
mechanisms. The  hi  light chain,  which is  required for the expression of this 
specificity, is present on 2-4% of all BALB/c serum antibodies and B cells (26, 
56,  60).  Since there is only one V  region and one J  region included in the hi 
complex (14), as opposed to hundreds of V~ genes, which recombine with four 
J~ genes (17),  this  one Vx, Jx  sequence is  apparently used at  a  higher overall 
frequency than the average use of given V~, J, combinations would be. Therefore, 
we anticipate that clonotypes that  use the hi  gene would have a  substantially 
higher probability of expression than clonotypes using most K  genes. Additionally, 
an analysis of the ~,-bearing a(1 ~  3) DEX-specific clonotype family in BALB/c 
mice showed that, whereas apparently only one VH gene was used in this family, 
rearrangement with any of several D  segments, and at  least two J.  segments, 
could yield an appropriate H  chain (44,  61). Thus, it is perhaps not surprising 
that B cells expressing appropriate light and heavy chains for the expression of 
the  h-bearing a(1  --o  3)  DEX-specific clonotype family could be  many times 
higher, as demonstrated herein, than those expressing the ARS IdX in A/J mice. 
However, the postulated stochastic use of V gene segments may be an oversim- 
plified explanation for clonotype expression, since it could not account for the 
high frequency of expression of the TEPC-15 idiotype-bearing PC-responsive B 
cells in the sIg- precursor pool of BALB/c mice (25). TEPC-15 expression can 
use only a single VH, D, J., VL, and JL (62). Additionally, it has been shown (25) 
that the high frequency of TEPC-15  expression is due to a  high frequency of 
occurrence of this cionotype from within the bone marrow pool, rather than the 
expression of unusually large clones of this clonotype. This would indicate that, 
while the stochastic probability of the rearrangement of V region gene elements 
from within the entire gene pool may be one of the factors that determine the 
level of expression of certain clonotypes, the expression of at least some specific- 
ities may reflect a  higher than  random probability of gene rearrangement of 
various V region gene elements. 
The frequency of C.B20  splenic B cells that yield h-bearing a(1 ---* 3) DEX- 
specific antibodies is less than a tenth the frequency found in splenic B cells of 1628  SILENCING  OF  A  PREDOMINANT  CLONOTYPE  FAMILY 
BALB/c mice, regardless of the Igh haplotype of the carrier-primed recipients 
used. This finding is consistent with the well-established phenotypic difference 
in both serum antibodies and precursor cells in these two strains (7-9, 40, 43). 
Remarkably, the frequency of )`-bearing a(1  ~  3)  DEX-specific antibody re- 
sponses  obtained  from  sIg-  C.B20  bone  marrow cells transferred to  carrier- 
primed BALB/c (Igh  a) recipients is higher than the frequency of responses of 
this specificity found in C.B20 splenic B cells on a per-injected-cell basis,  and is 
at  least as  high  as  the  frequency observed in  sIg-  bone  marrow cells of the 
responder BALB/c strain.  This finding indicates that there is no deficiency in 
the capacity of stem cells of Igh  b mice to generate precursor cells expressing the 
appropriate  rearranged V  genes necessary for the )`-bearing a(1  ~  3)  DEX- 
specific cells. The finding that cells of this specificity are apparently inactivated 
or silenced during their maturation  implies that the classical  phenotypic poly- 
morphism  in  the  expression  of )`-bearing  a(1  ~  3)  DEX-specific antibodies 
between Igh  ~ and Igh  b mice is the product of environmental regulatory mecha- 
nisms, as opposed to differences in V region gene expression. 
To verify this surprising finding by an additional methodologic approach, and 
to obtain sufficient antibodies and cells for qualitative analyses, we have estab- 
lished ),-bearing a(1 ~  3) DEX-specific hybridomas using C.B20 bone marrow 
cells. The proportion of ),-bearing a(1 ~  3) DEX-specific hybridomas obtained 
from transfer fusions using C.B20 bone marrow cells and BALB/c recipients was 
consistent with the proportional representation of monoclonal fragment culture 
responses of this specificity among all responses to DEX-Hy obtained using the 
same donor cell-recipient combination.  Characterization of these hybridomas 
indicates that the antibodies bear the IdX idiotypic determinant common to most 
BALB/c antibodies of this specificity (7-9, 43, 44). This finding represents the 
first demonstration, in the absence of any idiotype-selective manipulation, of the 
natural potential of C.B20 (Igh  b) mice to generate antibody-producing cells that 
secrete X-bearing a(1 ~  3) DEX-specific antibodies expressing the IdX idiotypic 
determinants. 
Recent studies from several laboratories (34-39,  63,  64) have demonstrated 
the induction of silent clonotypes in  several responses.  For example, the ARS 
IdX + antibodies, normally a characteristic of responses of A/J mice, have been 
induced  in  BALB/c  mice  (63,  64).  Additionally,  the  bacterial  levan  A481d 
clonotype  (34),  and  the  DEX  IdX +  clonotypes  normally  characteristic  of 
BALB/c mice (38,  43),  have been induced in  Igh  b mice.  In all of these cases, 
expression  of the  silent  clonotype  required  selective  idiotypic  manipulations 
(administration or induction of the antiidiotype, followed, after a  considerable 
rest period, by antigenic stimulation), and thereby differ significantly from the 
findings  reported  herein.  By  exerting a  selective  manipulation,  a  rare  clone 
bearing the marker in question may be expanded, resulting in a large population 
of cells of the normally silent clonotype being present at the time of antigenic 
stimulation. The presence of this silent clonotype therefore may bear little di- 
rect  relationship  to  the  animal's  naturally  expressed  repertoire.  In  the  one 
system wherein V region sequence data is available, the ARS IdX  + response of 
BALB/c  mice,  the  newly  selected  clonotype  in  BALB/c  mice  uses  a  totally 
different V.  gene segment than  that  used by A/J  B  cells (64).  In  the studies 
described  in  this  report,  C.B20  sIg-  bone  marrow  cells  of the  X-bearing FROSCHER  AND  KLINMAN  1629 
o~(1 ~  3) DEX-specific clonotype respond to antigen at the same frequency as 
BALB/c slg- bone marrow cells of this clonotype with no prior selective idiotypic 
manipulation. Therefore, these cells presumably represent the direct expression 
of the genetically encoded repertoire of C.B20 mice. 
Since dextran is a  naturally occuring environmental antigen, several mecha- 
nisms could potentially account for the low expression of ~-bearing o~(1 --~ 3) 
DEX-specific responses in Igh  b mice. These include tolerance, clonal dominance 
of ~-bearing B cells, antiidiotypic suppression and clonotype-specific differences 
in T  cell help. In the latter two instances, stimulation of B cells in Igh allogeneic 
rather  than  syngeneic recipients  could  facilitate  their  activation.  Specifically, 
previous experiments (45) have shown that both immature and mature primary 
B cells are highly susceptible in  fragment culture to  inactivation by antibody- 
specific immunoregulatory mechanisms which can, for example, reside in recip- 
ients primed with both  the hapten  and carrier rather than  the carrier alone. 
Importantly, this suppression is totally specific for primary B cells that share the 
Igh haplotype of the recipient. The finding that sIg- C.B20 ~,-bearing a(1 ~  3) 
DEX-specific precursor cells respond in the carrier-primed Igh  a allogeneic but 
not the Igh  b syngeneic environment suggests the presence of a preexisting Igh- 
linked suppressive network in  the C.B20  recipients similar to that induced by 
hapten-carrier (45) or viral (46) immunization. In this context, these findings are 
compatible with the conclusion that natural exposure of C.B20 but not BALB/c 
mice to dextran induces an environmental milieu that downregulates C.B20  X- 
bearing oz(1 ~  3)  DEX-specific B  cells.  The  C.B20  suppressive  environment 
does not affect the expression of BALB/c splenic or sIg- precursor cells of this 
clonotype. This suggests that the C.B20 environment supplies sufficient antigen 
processing and  T  cell help  for the stimulation  of ~,-bearing o~(1 ~  3)  DEX- 
specific clones, and may imply that the V  regions used by these two strains for 
this response differ in amino acid sequence, or that the suppressive mechanism 
is  allotype-dependent, as  has  been  previously reported  (46)  for  responses  to 
influenza. The demonstration that fragment cultures derived from C.B20 recip- 
ients contain a naturally acquired suppressive mechanism may also implicate the 
same mechanism in the suppression of X-bearing oz(1 ~  3) DEX-specific C.B20 
B cells during their development in situ. If this is the case, then the demonstration 
of the presence of DEX-responsive X-bearing a(1 --~ 3)-specific cells in sIg- bone 
marrow cells, and their absence in the mature bone marrow and splenic B cells 
in C.B20 mice may represent the first evidence of a role for naturally acquired 
network-type regulation in fashioning the primary B cell repertoire. 
Summary 
The  immune  response  to  dextran  is  characterized by  marked  phenotypic 
differences among  murine  strains.  In  particular,  Igh  a strains,  as  opposed  to 
strains of other Igh haplotypes, respond relatively vigorously to dextran B 1355 
fraction S (DEX), producing predominantly antibodies bearing the ~ light chain, 
and specific for the a(1 ~  3) glucose linkage. We have investigated this disparity 
in  BALB/c (Igh  a) vs.  C.B20  (Igh  b) mice at the individual precursor cell level. 
Consistent  with  previous findings (7-9,  35,  40,  42,  43),  there  was a  10-fold 
higher frequency of ~-bearing splenic B cells specific for the a(1 ---* 3) linkage in 
Igh  ~L  mice.  As  with  previously  studied  (25-27)  predominant  specificities,  the 1630  SILENCING  OF  A  PREDOMINANT  CLONOTYPE  FAMILY 
origin of this high frequency of X-bearing a(1 --+ 3) DEX-specific B cells appears 
to  be  a  reflection  of a  high  expression  of this  specificity in  surface  Ig  (sIg)- 
negative cells emerging from the bone marrow generative cell pool. Surprisingly, 
although C.B20 mice (Igh  b) have a  low frequency of X-bearing ~(1  ~  3) DEX- 
specific  B  cells  in  their  mature  primary  splenic  population,  the  frequency of 
precursor  cells  of this  clonotype in  their  sIg-  bone  marrow  cell population  is 
equivalent to that of BALB/c sIg- cells. These cells could only be stimulated in 
allotype allogeneic (Igha), as opposed to ailotype syngeneic (Ighb), carrier-primed 
irradiated  recipients.  This  finding  was  confirmed  by  the  finding  that  a  high 
proportion ofantidextran hybridoma cell lines derived from C.B20 bone marrow 
cells  produced  X-bearing  ~(1  --+  3)  DEX-specific  antibodies  that  were  IdX +. 
These  findings  have  led  us  to  conclude  that  the  well-established  phenotypic 
difference between Igh  a and Igh  b mice with respect to the expression of X-bearing 
~(1  ~  3) DEX-specific antibody responses is not, as previously assumed (7-9), 
the result of an inability of Igh  b mice to generate B cells of this clonotype, but 
rather, is the product of environmental, possibly antiidiotypic, silencing of cells 
of this clonotype as they mature in Igh  b mice. 
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